Instrument Inactif

Communiqués PCI Biotech Oslo Bors

Actions

Recherche biotechnologique et médicale

Communiqués

07/04	PCI Biotech : OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH	PU
24/03	PCI Biotech : Delisting	PU
17/03	Received application for delisting	AQ
16/03	Minutes from Extraordinary General Meeting	GL
23/02	PCI Biotech : Proposed resolutions for the EOGM 16 March 2026	PU
23/02	Notice of Extraordinary General Meeting, proposed company dissolution and delisting	GL
23/02	PCI Biotech : OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH	PU
30/01	PCI Biotech Holding ASA is placed in Recovery Box	AQ
29/01	PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process	GL
08/01	PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options	GL
23/10/25	PCI Biotech update	GL
25/09/25	PCI Biotech update on future operations	GL
29/08/25	PCI Biotech : 1H 2025 (PCI Biotech 1H 2025 Interim Report)	PU
29/08/25	PCI Biotech : 1H 2025 (PCI Biotech 1H 2025 Presentation)	PU
29/08/25	PCI Biotech half-year interim 2025 report	GL
27/08/25	PCI Biotech - Invitation to first half 2025 results presentation and corporate update	AQ
26/08/25	PCI Biotech: Invitation to first half 2025 results presentation and corporate update	GL
22/08/25	Flaggemelding	GL
22/08/25	Flaggemelding	GL
18/08/25	PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations	GL
23/05/25	PCI Biotech Holding ASA - Minutes of Annual General Meeting 2025	AQ
22/05/25	PCI Biotech: Minutes of Annual General Meeting 2025	GL
30/04/25	PCI Biotech : Notice AGM 2025	PU
30/04/25	PCI Biotech : Proposed resolutions for the AGM 2025	PU
30/04/25	PCI Biotech : Remuneration Report 2024	PU